ID

42250

Beschrijving

Study ID: 104864/410 Clinical Study ID: 104864/410 Study Title: A randomised open-label multicentre Phase II study to evaluate the safety and efficacy of intravenous topotecan given with either cisplatin or etoposide every 21 days as first-line therapy in patients with extensive-disease (ED) small-cell lung cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Study Indication: Lung Cancer

Trefwoorden

Versies (1)
  1. 18-04-21 18-04-21 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

18 april 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

  • Nieuwste
  • Oudste
  • Populair
  • Nieuwste
    • Nieuwste
    • Oudste
    • Populair

Geen commentaren

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Safety and efficacy of topotecan in patients with extensive-disease small-cell lung cancer (104864/410)

Engels

Screening - Prior an Concomitant Medication; Telephone Randomisation

1 Formulieren  
Administrative
Beschrijving

Administrative

Alias
UMLS CUI-1
C1320722
Patient Number
Beschrijving

Patient Number

Datatype

text

Alias
UMLS CUI [1]
C2348585
Patient Initials
Beschrijving

Patient Initials

Datatype

text

Alias
UMLS CUI [1]
C2986440
Prior and Concomitant Medication
Beschrijving

Prior and Concomitant Medication

Alias
UMLS CUI-1
C2826257
UMLS CUI-2
C2347852
Has the patient taken any medication in the past 30 years?
Beschrijving

If "Yes" please record details below. Where appropriate, medical conditions should be recorded in the Significant Medical/ Surgical History and Physical examination section, utilising the same terminology. Record PM for prophylactic treatment with the Medical Condition for prophylactically administered medications.

Datatype

boolean

Alias
UMLS CUI [1]
C2826257
Prior and Concomitant Medication
Beschrijving

Prior and Concomitant Medication

Alias
UMLS CUI-1
C2826257
UMLS CUI-2
C2347852
Drug Name
Beschrijving

Trade Name preferred

Datatype

text

Alias
UMLS CUI [1]
C0013227
Total Daily Dose
Beschrijving

Total Daily Dose

Datatype

text

Alias
UMLS CUI [1,1]
C2348070
UMLS CUI [1,2]
C0013227
Administration Route
Beschrijving

Administration Route

Datatype

text

Alias
UMLS CUI [1]
C0013153
Medical Condition
Beschrijving

Medical Condition

Datatype

text

Alias
UMLS CUI [1]
C0012634
Medication Start Date
Beschrijving

Medication Start Date

Datatype

date

Alias
UMLS CUI [1]
C2826734
Medication End Date
Beschrijving

Medication End Date

Datatype

date

Alias
UMLS CUI [1]
C2826744
Medication Continuing
Beschrijving

Medication Continuing

Datatype

integer

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0549178
Telephone Randomisation
Beschrijving

Telephone Randomisation

Alias
UMLS CUI-1
C0039457
UMLS CUI-2
C0034656
Has the patient been registered and randomised using the centralised telephone system?
Beschrijving

If "Yes" please record the patient's randomisation number

Datatype

boolean

Alias
UMLS CUI [1]
C1514821
UMLS CUI [2]
C0034656
UMLS CUI [3]
C0039457
Randomisation Number
Beschrijving

Randomisation Number

Datatype

text

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
Patient's randomised treatment arm
Beschrijving

Patient's randomised treatment arm

Datatype

text

Alias
UMLS CUI [1]
C1522541
Terug naar het begin van de pagina

Similar models

Screening - Prior an Concomitant Medication; Telephone Randomisation

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Patient Number
Item
Patient Number
text
C2348585 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Prior and Concomitant Medication
C2826257 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Has the patient taken any medication in the past 30 years?
Item
Has the patient taken any medication in the past 30 years?
boolean
C2826257 (UMLS CUI [1])
Item Group
Prior and Concomitant Medication
C2826257 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Drug Name
Item
Drug Name
text
C0013227 (UMLS CUI [1])
Total Daily Dose
Item
Total Daily Dose
text
C2348070 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Administration Route
Item
Administration Route
text
C0013153 (UMLS CUI [1])
Medical Condition
Item
Medical Condition
text
C0012634 (UMLS CUI [1])
Medication Start Date
Item
Medication Start Date
date
C2826734 (UMLS CUI [1])
Medication End Date
Item
Medication End Date
date
C2826744 (UMLS CUI [1])
Item
Medication Continuing
integer
C0013227 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Medication Continuing
Code List
Medication Continuing
CL Item
Medication Continuing (1)
Item Group
Telephone Randomisation
C0039457 (UMLS CUI-1)
C0034656 (UMLS CUI-2)
Has the patient been registered and randomised using the centralised telephone system?
Item
Has the patient been registered and randomised using the centralised telephone system?
boolean
C1514821 (UMLS CUI [1])
C0034656 (UMLS CUI [2])
C0039457 (UMLS CUI [3])
Randomisation Number
Item
Randomisation Number
text
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Item
Patient's randomised treatment arm
text
C1522541 (UMLS CUI [1])
Patient's randomised treatment arm
Code List
Patient's randomised treatment arm
CL Item
Regimen 1 - Topotecan for 5 Days and Cisplatin on Day 5 (TC)
CL Item
Regimen 2 - Topotecan for 5 Days and Etoposide for 5 Days (TE)
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial